U.S. Markets closed

Haemonetics Corporation (HAE)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
40.13-0.15 (-0.37%)
At close: 4:02PM EDT

40.13 0.00 (0.00%)
After hours: 6:27PM EDT

People also watch
ICUIIVCCNMDIARTCOO

Haemonetics Corporation

400 Wood Road
Braintree, MA 02184
United States
781-848-7100
http://www.haemonetics.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Mr. Christopher SimonChief Exec. Officer, Pres and DirectorN/AN/A53
Mr. William P. BurkeChief Financial Officer and Exec. VPN/AN/AN/A
Mr. Neil RydingExec. VP of Global OperationsN/AN/A56
Mr. Dan GoldsteinPrincipal Accounting Officer, VP and Corp. ControllerN/AN/A40
Mr. Gerard J. GouldVP of Investor RelationsN/AN/A63
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Haemonetics Corporation, a healthcare company, provides products for processing, handling, and analysis of blood. The company operates through five segments: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection, filtration, and processing products. The company also offers hospital products comprising TEG thrombelastograph hemostasis analyzer system, a blood diagnostic instrument that measure a patient’s hemostasis or the ability to form and maintain blood clots; Cell Saver system, a surgical blood salvage system for cardiovascular surgeries; and OrthoPAT surgical blood salvage systems for orthopedic procedures. In addition, it offers SafeTrace Tx, a software solution that manages blood product inventory and transfusion, as well as performs patient cross-matching; and BloodTrack suite of solutions for managing, tracking, and controlling blood products from the hospital blood center through to transfusion to the patient. The company markets and sells its products to bio-pharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.

Corporate Governance

Haemonetics Corporation’s ISS Governance QualityScore as of May 1, 2017 is 6. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 7; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.